Lung Cancer: What Are Skeletal-Related Events? | ZOMETA®

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

About ZOMETA: defend against SREs across a broad range of tumor types

Bone metastases can lead to skeletal-related events (SREs) with
debilitating consequences

SREs are generally defined as³
- — Pathologic fractures
- — Radiation or surgery to bone
- — Spinal cord compression
- — Tumor-induced hypercalcemia

SREs have debilitating consequences for the patient³
- — Bone pain
- — Increased healthcare costs
- — Loss of autonomy and reduced quality of life
- — Shortened survival

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Bone metastases can lead to skeletal-related events (SREs) withdebilitating consequences

Bone metastases can lead to skeletal-related events (SREs) with
debilitating consequences